{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:12:13Z","timestamp":1747455133122,"version":"3.40.5"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["Statistical Trial Design"],"award-info":[{"award-number":["Statistical Trial Design"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["Clinical Trials"],"award-info":[{"award-number":["Clinical Trials"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"crossref","award":["Tier 1"],"award-info":[{"award-number":["Tier 1"]}],"id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Bronchiolitis exerts a high burden on children, their families and the healthcare system. The Canadian Bronchiolitis Epinephrine Steroid Trial (CanBEST) assessed whether administering epinephrine alone, dexamethasone alone, or in combination (EpiDex) could reduce bronchiolitis-related hospitalizations among children less than 12 months of age compared to placebo. CanBEST demonstrated a statistically significant reduction in 7-day hospitalization risk with EpiDex in an unadjusted analysis but not after adjustment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>To explore the probability that EpiDex results in a reduction in hospitalizations using Bayesian methods.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Study design<\/jats:title>\n<jats:p>Using prior distributions that represent varying levels of preexisting enthusiasm or skepticism, i.e., how confident or doubtful one is that EpiDex may reduce hospitalizations, and information about the treatment effect <jats:italic>before<\/jats:italic> data were collected, the posterior distribution of the relative risk of hospitalization compared to placebo was determined. The probability that the treatment effect is less than 1, 0.9, 0.8 and 0.6, indicating increasing reductions in hospitalization risk, are computed alongside 95% credible intervals.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Combining a minimally informative prior distribution with the data from CanBEST provides comparable results to the original analysis. Unless strongly skeptical views about the effectiveness of EpiDex were considered, the 95% credible interval for the treatment effect lies below 1, indicating a reduction in hospitalizations. There is a 90% probability that EpiDex results in a clinically meaningful reduction in hospitalization of 10% even when incorporating skeptical views, with a 67% probability when considering strongly skeptical views.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>A Bayesian analysis demonstrates a high chance that EpiDex reduces hospitalization rates for bronchiolitis, although strongly skeptical individuals may require additional evidence to change practice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:bold>Clinical Trial registry name, registration number<\/jats:bold>: Current Controlled Trials number, ISRCTN56745572<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0318853","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T17:29:05Z","timestamp":1747416545000},"page":"e0318853","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Larry","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-7091","authenticated-orcid":true,"given":"Terry P.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda","family":"Correll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maala","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4580-2023","authenticated-orcid":true,"given":"Hema","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen J. L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy W. S.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra R.","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Plint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-4251","authenticated-orcid":true,"given":"Anna","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"1","key":"pone.0318853.ref001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1542\/peds.2007-2087","article-title":"Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan","volume":"122","author":"KN Carroll","year":"2008","journal-title":"Pediatrics"},{"issue":"15","key":"pone.0318853.ref002","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis-associated hospitalizations among US children, 1980-1996","volume":"282","author":"D Shay","year":"1999","journal-title":"JAMA"},{"issue":"11","key":"pone.0318853.ref003","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1086\/379740","article-title":"Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980\u20132000","volume":"188","author":"JM Langley","year":"2003","journal-title":"J Infect Dis"},{"key":"pone.0318853.ref004","first-page":"65","article-title":"Infectious disease","volume-title":"Respiratory disease in Canada","author":"H Njoo","year":"2001"},{"key":"pone.0318853.ref005","volume-title":"Monitoring the health of New Zealand children and young people: Indicator handbook","author":"NZCYES Steering Committee","year":"2007"},{"issue":"10065","key":"pone.0318853.ref006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(16)30951-5","article-title":"Viral bronchiolitis","volume":"389","author":"TA Florin","year":"2017","journal-title":"Lancet"},{"key":"pone.0318853.ref007","first-page":"1","article-title":"Epinephrine for bronchiolitis","volume":"6","author":"L Hartling","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"pone.0318853.ref008","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1056\/NEJMoa0900544","article-title":"Epinephrine and dexamethasone in children with bronchiolitis","volume":"360","author":"AC Plint","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0318853.ref009","first-page":"189","article-title":"Why we (usually) don\u2019t have to worry about multiple comparisons","volume":"5","author":"A Gelman","year":"2012","journal-title":"J Res Educ Eff"},{"issue":"22","key":"pone.0318853.ref010","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2015.10.014","article-title":"Making sense of statistics in clinical trial reports","volume":"66","author":"SJ Pocock","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"pone.0318853.ref011","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"R Bender","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"pone.0318853.ref012","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10654-019-00517-2","article-title":"Frequentist versus Bayesian approaches to multiple testing","volume":"34","author":"A Sj\u00f6lander","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"pone.0318853.ref013","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/peds.2009-2092","article-title":"Bronchiolitis: recent evidence on diagnosis and management","volume":"125","author":"JJ Zorc","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"pone.0318853.ref014","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1183\/09031936.00080306","article-title":"Scientific rationale for using a single inhaler for asthma control","volume":"29","author":"PJ Barnes","year":"2007","journal-title":"Eur Respir J"},{"issue":"6","key":"pone.0318853.ref015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.bjp.0707627","article-title":"A holy grail of asthma management: toward understanding how long-acting beta2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids","volume":"153","author":"M Giembycz","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"pone.0318853.ref016","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/mol.107.038794","article-title":"Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?","volume":"72","author":"R Newton","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"1","key":"pone.0318853.ref017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/mol.107.040121","article-title":"Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells","volume":"73","author":"M Kaur","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"49","key":"pone.0318853.ref018","doi-asserted-by":"crossref","first-page":"19713","DOI":"10.1073\/pnas.1110226108","article-title":"\u03b22-adrenoceptor agonist-induced rgs2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids","volume":"108","author":"N Holden","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8917","key":"pone.0318853.ref019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(94)92996-3","article-title":"Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group","volume":"344","author":"AP Greening","year":"1994","journal-title":"Lancet"},{"issue":"20","key":"pone.0318853.ref020","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma","volume":"337","author":"RA Pauwels","year":"1997","journal-title":"N Engl J Med"},{"issue":"7166","key":"pone.0318853.ref021","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.317.7166.1151","article-title":"Bayesians and frequentists","volume":"317","author":"JM Bland","year":"1998","journal-title":"BMJ"},{"issue":"6","key":"pone.0318853.ref022","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1740774519871471","article-title":"Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update","volume":"16","author":"RSS Tidwell","year":"2019","journal-title":"Clin Trials"},{"issue":"21","key":"pone.0318853.ref023","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1002\/sim.2672","article-title":"Bayesian statistics in medicine: a 25 year review","volume":"25","author":"D Ashby","year":"2006","journal-title":"Stat Med"},{"issue":"25","key":"pone.0318853.ref024","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/sim.5404","article-title":"Bayesian clinical trials in action","volume":"31","author":"JJ Lee","year":"2012","journal-title":"Stat Med"},{"issue":"12","key":"pone.0318853.ref025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.7326\/0003-4819-130-12-199906150-00008","article-title":"Toward evidence-based medical statistics. 1: the p value fallacy","volume":"130","author":"SN Goodman","year":"1999","journal-title":"Ann Intern Med"},{"key":"pone.0318853.ref026","volume-title":"Bayesian statistics: an introduction","author":"P Lee","year":"1989"},{"issue":"21","key":"pone.0318853.ref027","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2018.14276","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial","volume":"320","author":"EC Goligher","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"pone.0318853.ref028","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00031305.1987.10475458","article-title":"Interim analysis in clinical trials: the role of the likelihood principle","volume":"41","author":"DA Berry","year":"1987","journal-title":"Am Stat"},{"issue":"1","key":"pone.0318853.ref029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00485695","article-title":"Frequentist probability and frequentist statistics","volume":"36","author":"J Neyman","year":"1977","journal-title":"Synthese"},{"issue":"435","key":"pone.0318853.ref030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/01621459.1996.10477003","article-title":"The selection of prior distributions by formal rules","volume":"91","author":"R Kass","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"pone.0318853.ref031","doi-asserted-by":"crossref","DOI":"10.1002\/9780470746684","volume-title":"Decision theory: principles and approaches","author":"G Parmigiani","year":"2009"},{"issue":"3","key":"pone.0318853.ref032","doi-asserted-by":"crossref","DOI":"10.1214\/08-BA318","article-title":"Objections to Bayesian statistics","volume":"3","author":"A Gelman","year":"2008","journal-title":"Bayesian Anal"},{"key":"pone.0318853.ref033","first-page":"509","article-title":"Bayesian meta-analysis.","volume-title":"Statistical methodology in the pharmaceutical sciences","author":"W. DuMouchel","year":"1990"},{"issue":"2","key":"pone.0318853.ref034","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1541-0420.2007.00888.x","article-title":"Determining the effective sample size of a parametric prior","volume":"64","author":"S Morita","year":"2008","journal-title":"Biometrics"},{"key":"pone.0318853.ref035","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.55","article-title":"Probabilistic programming in python using pymc3","volume":"2","author":"J Salvatier","year":"2016","journal-title":"PeerJ Comput Sci"},{"key":"pone.0318853.ref036","doi-asserted-by":"crossref","DOI":"10.1201\/b16018","volume-title":"Bayesian data analysis","author":"A Gelman","year":"2013"},{"issue":"10","key":"pone.0318853.ref037","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.39884","article-title":"Admissions for Bronchiolitis at Children\u2019s Hospitals Before and During the COVID-19 Pandemic","volume":"6","author":"KA Remien","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10349","key":"pone.0318853.ref038","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(22)01016-9","article-title":"Bronchiolitis","volume":"400","author":"S Dalziel","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"pone.0318853.ref039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028511","article-title":"Safety of corticosteroids in young children with acute respiratory conditions: a systematic review and meta-analysis","volume":"9","author":"RM Fernandes","year":"2019","journal-title":"BMJ Open"},{"key":"pone.0318853.ref040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d1714","article-title":"Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis","volume":"342","author":"L Hartling","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"pone.0318853.ref041","article-title":"The acute bronchiolitis rebound in children after COVID-19 restrictions: a retrospective, observational analysis","volume":"94","author":"A Curatola","year":"2023","journal-title":"Acta Biomed"},{"issue":"2","key":"pone.0318853.ref042","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-024-03431-7","article-title":"Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults","volume":"31","author":"Z Du","year":"2025","journal-title":"Nat Med"},{"issue":"34","key":"pone.0318853.ref043","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of Nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices - United States, 2023","volume":"72","author":"JM Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0318853.ref044","author":"A Plint","year":"2022"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T17:29:14Z","timestamp":1747416554000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318853"}},"subtitle":[],"editor":[{"given":"Dhammika Leshan","family":"Wannigama","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318853","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}